Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021.

Harder, Thomas; Külper-Schiek, Wiebe; Reda, Sarah; Treskova-Schwarzbach, Marina; Koch, Judith; Vygen-Bonnet, Sabine; Wichmann, Ole

Harder, Thomas; Külper-Schiek, Wiebe; Reda, Sarah; Treskova-Schwarzbach, Marina; Koch, Judith; Vygen-Bonnet, Sabine; Wichmann, Ole.

Afiliação

Harder T; Robert Koch Institute, Berlin, Germany.
Külper-Schiek W; Robert Koch Institute, Berlin, Germany.
Reda S; Robert Koch Institute, Berlin, Germany.
Treskova-Schwarzbach M; Robert Koch Institute, Berlin, Germany.
Koch J; Robert Koch Institute, Berlin, Germany.
Vygen-Bonnet S; Robert Koch Institute, Berlin, Germany.
Wichmann O; Robert Koch Institute, Berlin, Germany.

Euro Surveill ; 26(41)2021 10.

Article em En | MEDLINE | ID: mdl-34651577

Assuntos

Vacinas contra COVID-19; COVID-19; Hospitalização; Humanos; SARS-CoV-2

Palavras-chave

COVID-19; Delta variant; SARS-CoV-2; systematic review; vaccination; vaccine effectiveness; variant of concern

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google